Fig. 3: Biochemical markers as predictor of disease severity and clinical course.
From: Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?
a C-reactive protein by treatment required for resolution of colitis (ANOVA: p = 0.12). b Haemoglobin by treatment required for resolution of colitis (ANOVA: p = 0.45). c Albumin by treatment required for resolution of colitis (ANOVA: p = 0.14).
